News & Events

See what’s new at DiFilippo Corporate Finance Group

At DCF Group, we are continually working to advance the practice of financial and tax-related valuation issues to benefit our clients. Learn about new transactions, new staff members, industry news, and upcoming events. Check back often to see the latest updates.


DCF Group’s clients were responsible for nearly 50% of all capital raised by Boston Startups in February 2022

VC funding update: Boston-area startups that raised money in February Read More

DCF Group clients made up 50% of top ten 2021 VC deals in MA Biotech

5 DCF clients make the 2021 list of top 10 Venture Capital Deals in Massachusetts Biotech Read More

DCF Group proudly worked on 7 of Fierce Biotech’s 2021 “Fierce 15”

Fierce Biotech has named their 2021 "Fierce 15", which designates the most promising early-stage biotechnology companies in the industry. Read More

DCF Group is proud to see 5 of their clients on the 2021 Endpoints 11 list

Endpoints News names the 11 most promising biotech startups of 2021. Read More

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

Biotechnology Company, Monte Rosa Therapeutics, Inc., announced the pricing of its initial public offering of 11,700,000 shares of common stock . Read More

DCF Group’s clients raised over 25% of all capital raised by Boston startups and tech firms in January 2021

VC funding update: Boston startups and tech firms raised $3.5B in January Read More

Tessera Therapeutics Attracts Over $230M in Series B Financing

Tessera Therapeutics announced that it has raised over $230M in Series B financing to Advance ‘Gene Writing’ – A New Category in Genetic Medicine. Read More